NASDAQ:HCM
Hutchmed China Ltd
- Stock
locale
Hong Kong
market
STOCKSindustry
Drug Manufacturers - Specialty & Genericwebsite
www.hutch-med.comipo date
May 19, 2006
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal canc...Show More
Earnings
Earnings Release in 2 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus